Sulfated Polysaccharide, Curdlan Sulfate, Efficiently Prevents Entry/Fusion and Restricts Antibody-Dependent Enhancement of Dengue Virus Infection In Vitro: A Possible Candidate for Clinical Application

被引:60
作者
Ichiyama, Koji [1 ,2 ]
Reddy, Sindhoora Bhargavi Gopala [1 ,3 ]
Zhang, Li Feng [1 ]
Chin, Wei Xin [1 ]
Muschin, Tegshi [4 ]
Heinig, Lars [1 ]
Suzuki, Youichi [1 ]
Nanjundappa, Haraprasad [3 ]
Yoshinaka, Yoshiyuki [5 ]
Ryo, Akihide [2 ]
Nomura, Nobuo [6 ]
Ooi, Eng Eong [7 ]
Vasudevan, Subhash G. [7 ]
Yoshida, Takashi [4 ]
Yamamoto, Naoki [1 ]
机构
[1] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Translat ID Lab, Singapore 117595, Singapore
[2] Yokohama City Univ, Sch Med, Dept Microbiol, Yokohama, Kanagawa 232, Japan
[3] Sri Jayachamarajendra Coll Engn, Dept Biotechnol, Mysore, Karnataka, India
[4] Kitami Inst Technol, Dept Bio & Environm Chem, Kitami, Hokkaido 090, Japan
[5] Tokyo Med & Dent Univ, Dept Mol Virol, Tokyo, Japan
[6] Musashino Univ, Dept Human Sci, Tokyo, Japan
[7] Duke NUS Grad Med Sch, Program Emerging Infect Dis, Singapore, Singapore
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; ENVELOPE PROTEIN; PLASMODIUM-FALCIPARUM; SELECTIVE INHIBITORS; ANTIVIRAL COMPOUNDS; HEMORRHAGIC-FEVER; DENDRITIC CELLS; DRUG DISCOVERY; DC-SIGN; ENTRY;
D O I
10.1371/journal.pntd.0002188
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Curdlan sulfate (CRDS), a sulfated 1 -> 3-beta-D glucan, previously shown to be a potent HIV entry inhibitor, is characterized in this study as a potent inhibitor of the Dengue virus (DENV). CRDS was identified by in silico blind docking studies to exhibit binding potential to the envelope (E) protein of the DENV. CRDS was shown to inhibit the DENV replication very efficiently in different cells in vitro. Minimal effective concentration of CRDS was as low as 0.1 mu g/mL in LLC-MK2 cells, and toxicity was observed only at concentrations over 10 mg/mL. CRDS can also inhibit DENV-1, 3, and 4 efficiently. CRDS did not inhibit the replication of DENV subgenomic replicon. Time of addition experiments demonstrated that the compound not only inhibited viral infection at the host cell binding step, but also at an early post-attachment step of entry (membrane fusion). The direct binding of CRDS to DENV was suggested by an evident reduction in the viral titers after interaction of the virus with CRDS following an ultrafiltration device separation, as well as after virus adsorption to an alkyl CRDS-coated membrane filter. The electron microscopic features also showed that CRDS interacted directly with the viral envelope, and caused changes to the viral surface. CRDS also potently inhibited DENV infection in DC-SIGN expressing cells as well as the antibody-dependent enhancement of DENV-2 infection. Based on these data, a probable binding model of CRDS to DENV E protein was constructed by a flexible receptor and ligand docking study. The binding site of CRDS was predicted to be at the interface between domains II and III of E protein dimer, which is unique to this compound, and is apparently different from the beta-OG binding site. Since CRDS has already been tested in humans without serious side effects, its clinical application can be considered.
引用
收藏
页数:17
相关论文
共 67 条
[1]   Dengue virus type 2 envelope protein displayed as recombinant phage attachment protein reveals potential cell binding sites [J].
Abd-Jamil, Juraina ;
Cheah, Chen-Yee ;
AbuBakar, Sazaly .
PROTEIN ENGINEERING DESIGN & SELECTION, 2008, 21 (10) :605-611
[2]   Alternative infectious entry pathways for dengue virus serotypes into mammalian cells [J].
Acosta, Eliana G. ;
Castilla, Viviana ;
Damonte, Elsa B. .
CELLULAR MICROBIOLOGY, 2009, 11 (10) :1533-1549
[3]   Antiviral activity of carbohydrate-binding agents and the role of DC-SIGN in dengue virus infection [J].
Alen, Marijke M. F. ;
Kaptein, Suzanne J. F. ;
De Burghgraeve, Tine ;
Balzarini, Jan ;
Neyts, Johan ;
Schols, Dominique .
VIROLOGY, 2009, 387 (01) :67-75
[4]  
[Anonymous], 2002, Dengue and Dengue Haemorrhagic Fever
[5]  
[Anonymous], 2012, SCHROD SUIT 2012 IND
[6]   SULFATED POLYSACCHARIDES ARE POTENT AND SELECTIVE INHIBITORS OF VARIOUS ENVELOPED VIRUSES, INCLUDING HERPES-SIMPLEX VIRUS, CYTOMEGALO-VIRUS, VESICULAR STOMATITIS-VIRUS, AND HUMAN IMMUNODEFICIENCY VIRUS [J].
BABA, M ;
SNOECK, R ;
PAUWELS, R ;
DECLERCQ, E .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (11) :1742-1745
[7]   Ligation of Fc gamma receptor IIB inhibits antibody-dependent enhancement of dengue virus infection [J].
Chan, Kuan Rong ;
Zhang, Summer Li-Xin ;
Tan, Hwee Cheng ;
Chan, Ying Kai ;
Chow, Angelia ;
Lim, Angeline Pei Chiew ;
Vasudevan, Subhash G. ;
Hanson, Brendon J. ;
Ooi, Eng Eong .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (30) :12479-12484
[8]   Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate [J].
Chen, YP ;
Maguire, T ;
Hileman, RE ;
Fromm, JR ;
Esko, JD ;
Linhardt, RJ ;
Marks, RM .
NATURE MEDICINE, 1997, 3 (08) :866-871
[9]   Structural Optimization and De Novo Design of Dengue Virus Entry Inhibitory Peptides [J].
Costin, Joshua M. ;
Jenwitheesuk, Ekachai ;
Lok, Shee-Mei ;
Hunsperger, Elizabeth ;
Conrads, Kelly A. ;
Fontaine, Krystal A. ;
Rees, Craig R. ;
Rossmann, Michael G. ;
Isern, Sharon ;
Samudrala, Ram ;
Michael, Scott F. .
PLOS NEGLECTED TROPICAL DISEASES, 2010, 4 (06)
[10]   A time-of-drug addition approach to target identification of antiviral compounds [J].
Daelemans, Dirk ;
Pauwels, Rudi ;
De Clercq, Erik ;
Pannecouque, Christophe .
NATURE PROTOCOLS, 2011, 6 (06) :925-933